The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 multicenter clinical trial to evaluate the safety and efficacy of abenacianine for injection (VGT-309), a tumor-targeted, intraoperative molecular imaging agent, for patients undergoing surgery for cancer in the lung.
 
Sunil Singhal
No Relationships to Disclose
 
Luis Herrera
Speakers' Bureau - Biodesix; Intuitive Surgical
 
Gavin Wright
Consulting or Advisory Role - BMSi; Ethicon/Johnson & Johnson; Medtronic; Merck
Research Funding - Imugene (Inst); Lexington Medical Center (Inst); Pulmonx (Inst); Vergent Bioscience (Inst)
Travel, Accommodations, Expenses - Vergent Bioscience
Other Relationship - Device Technologies (Inst); Ethicon/Johnson & Johnson (Inst)
 
Jae Kim
Honoraria - AstraZeneca; Regeneron
Consulting or Advisory Role - AstraZeneca
Research Funding - Lilly (Inst)
 
Janani Reisenauer
Honoraria - Elucent Medical; Elucent Medical; Intuitive Surgical (Inst)
Patents, Royalties, Other Intellectual Property - Alpenglow; JelloX; Mediview; Phase
 
David Rice
Honoraria - Intuitive Surgical
Consulting or Advisory Role - Intuitive Surgical
Research Funding - Intuitive Surgical (Inst); Vergent Bioscience (Inst)
Travel, Accommodations, Expenses - Intuitive Surgical